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Abstract
A high specificity does not ensure that the expected benefit of a diagnostic test outweighs its cost. Problems arise, in
particular, when the investigation is expensive, the prevalence of a positive test result is relatively small for the candidate
patients, and the sensitivity of the test is low so that the information provided by a negative result is virtually negligible. The
consequence may be that a potentially useful test does not gain broader acceptance. Here we show how predictive
modeling can help to identify patients for whom the ratio of expected benefit and cost reaches an acceptable level so that
testing these patients is reasonable even though testing all patients might be considered wasteful. Our application example
is based on a retrospective study of the glycerol test, which is used to corroborate a suspected diagnosis of Menie`re’s
disease. Using the pretest hearing thresholds at up to 10 frequencies, predictions were made by K-nearest neighbor
classification or logistic regression. Both methods estimate, based on results from previous patients, the posterior
probability that performing the considered test in a new patient will have a positive outcome. The quality of the prediction
was evaluated using leave-one-out cross-validation, making various assumptions about the costs and benefits of testing.
With reference to all 356 cases, the probability of a positive test result was almost 0.4. For subpopulations selected by K-
nearest neighbor classification, which was clearly superior to logistic regression, this probability could be increased up to
about 0.6. Thus, the odds of a positive test result were more than doubled.
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Introduction
An ideal diagnostic test has a high sensitivity combined with a
high specificity. However, tests that are used in daily routine do
rarely conform to this ideal. Instead, it is often necessary to find a
reasonable trade-off between sensitivity and specificity. This means
that a high sensitivity is achieved by accepting a relatively low
specificity and, conversely, a high specificity is reached by
compromising sensitivity. Specific tests are typically used to
confirm (or ‘‘rule in’’) a suspected diagnosis [1]. Specificity is
synonymous for true-negative rate, PTN , which is related to the
false-positive rate, PFP, as PTN~1{PFP. A high specificity
implicates that it is unlikely to get a positive result in a patient that
does not have the disease tested for. Thus, a positive outcome of a
specific test is quite informative and can have substantial
therapeutic consequences. A negative result, by contrast, is of
little value if the sensitivity of the test is low. This follows from the
fact that sensitivity is synonymous for true-positive rate, PTP,
which is related to the false-negative rate, PFN , as PTP~1{PFN .
Because a low sensitivity implicates a high false-negative rate, a
negative outcome of an insensitive test is a likely event that does
not give a compelling reason to rule out the disease tested for.
The performance of a diagnostic test can be illustrated by
making use of the so-called ROC (receiver operating character-
istic) space, which is a two-dimensional scheme where the
horizontal axis represents the false-positive rate (PFP, identical
with 1 minus specificity) and the vertical axis represents the true-
positive rate (PTP, corresponding to the sensitivity). A binary
classification (e.g., disease present or absent) is represented by a
single point in ROC space. A diagnostic test resulting in a
continuous variable can be reduced to a binary classification by
specifying a threshold (cut-off) [2]. Variation of this threshold
affects the trade-off between sensitivity and specificity so that the
ROC space representation of the test is no longer a single point,
but a curve: the ROC curve[3–9]. The ROC space is ideally
suited to compare the performances of alternative tests in terms of
sensitivity and specificity. However, these two measures alone are
insufficient to assess how useful a given test is in clinical practice
and how its utility compares to other tests. The reason is that a
ROC space representation is independent of class probabilities
(i.e., the prevalences of disease and ‘‘non-disease’’) and that a
ROC analysis does not account for misclassification costs (i.e., the
costs for false-positive and false-negative test results) [10].
However, both aspects are of crucial importance for a cost-benefit
analysis of a test.
A positive outcome of a specific test corroborates the hypothesis
that the investigated patient has a certain condition (e.g., suffering
from a suspected disease, possibly restricted to a certain stage). If
the sensitivity is low or moderate, the test is most useful when it is
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applied to a population of patients that were pre-selected based on
the results of previous, more unspecific tests. For the sake of
simplicity, we refer to this population as the population of
candidate patients (the patients may, for example, be suspected of
having a certain disease). The term ‘test’ is understood here in a
broad sense, which in the definition by Power et al. [11] ‘‘includes
not only laboratory tests, imaging investigations and diagnostic procedures, but
also questions in history-taking and items in the physical examination". We
extend this definition by also including approaches which reach a
diagnostic conclusion from the combination of various clinical
data by means of a mathematical model.
For many specific tests there is little doubt that each candidate
patient should be tested. This is especially clear if the test causes no
harm or major discomfort to the patient, the cost is low, and the
benefit is obvious and uncontroversial. It is also clear that a
practice which provides minimal or no health benefit is typically
wasteful, regardless of its cost [12]. A more detailed cost-benefit
analysis is mainly of interest for cases in between, where it is not so
easy to decide whether the benefit outweighs the cost. As the exact
measures of costs and benefits are often debatable [13], different
investigators may come to different conclusions about the cost-
benefit ratio. Thus, tests falling into the latter category may be
controversial and not generally accepted.
To understand why a cost-benefit analysis decisively depends on
the prevalence of the condition tested for, it is useful to make the
simplifying assumption that, in the case of a specific test with
relatively low sensitivity, a patient benefits only from a positive
outcome. The expectation of the benefit is then proportional to the
prevalence. As a consequence, the ratio of expected benefit and
cost can be less than unity if the prevalence of the condition tested
for is too low in the population of candidate patients. Under such
circumstances one would generally decide against the test
(although cost-effectiveness is not always crucial for providing
medical interventions [12]). In deciding so, it is implicitly assumed
that the probability of the condition tested for is the same for all
candidate patients. However, this presumption is not necessarily
true. Although all candidate patients fulfill, by definition, certain
criteria, they may considerably differ with respect to parameters
that are not covered by the criteria. Even parameters covered may
differ. For example, if a criterion for including a patient is that a
certain parameter exceeds a specific threshold, some patients may
fulfill this condition much more clearly than others.
The question addressed in this article is to what extent
differences within the population of candidate patients can be
utilized to estimate, individually for each patient, a pre-test
probability that predicts the outcome of the considered test better
than does the prevalence calculated on the basis of all candidate
patients. Such predictive modeling could be used to identify
candidate patients for whom the ratio of expected benefit and cost
reaches an acceptable level so that testing is reasonable even
though testing the whole population might be considered wasteful.
Thus, in essence, the idea is to use predictive modeling for defining
a subpopulation of candidate patients in which the prevalence of
the condition tested for is higher than in the total population. The
motivation for this study came from our recent retrospective
analysis of a special test: the glycerol test, which is used to
corroborate a suspected diagnosis of Menie`re’s disease [14]. But
the methodological approach presented below is quite general,
and most concepts are almost universally applicable. With this in
view, the main ideas will be presented in a way that they can be
applied to basically any diagnostic test. A detailed analysis of our
glycerol-test data then serves as an illustrative example.
Some of the key concepts presented below are typically applied
in a different context, which may give rise to confusion. Thus, a
few clarifications shall be made in advance in order to prevent
misunderstanding. In essence, we propose a two-stage design,
where a laborious gold standard test is reserved to patients who
had a positive result in a preceding screening test. Indeed,
referring to the broad-sense definition given above, predictive
modeling with the aim to estimate the prospects of a considered
diagnostic test may itself be regarded as a diagnostic test, which is
virtual in nature, though: Instead of requiring a renewed
interaction with the patient, the procedure relies on information
from previous tests that was not fully exploited when assigning the
patients to the population of candidates. This means that decision
making based on predictive modeling may be regarded as
screening. The glycerol test, on the other hand, can formally be
considered as a gold standard test, although not for Menie`re’s
disease per se, but for a specific stage of the disease (not necessarily
implying that all patients pass through that stage). The evaluation
of data gathered in such a two-stage design is complicated by the
fact that patients screened negative are not further investigated
(see, e.g., section 7.2 in [15]). But this is an issue only for future
investigations. The present study is not affected by this problem,
because it relies on data that were obtained by unconditionally
testing all candidate patients. As to the ROC analyses presented
below, the goal is to assess how well specific prediction methods
(‘‘virtual screening tests’’) are able to forecast the outcome of a
medical test (glycerol test in our example). By contrast, comparable
analyses in other articles typically aim to assess how well a medical
test can detect a disease. Hence, when comparing methodological
aspects it should be born in mind that, with respect to the
theoretical framework, ‘‘result of predictive modeling’’ and ‘‘test
result’’ may correspond to ‘‘test result’’ and ‘‘disease status’’ in
other studies where the context is different. Finally, we want to
emphasize that this study is not about evaluating given methods.
The original objective was to find a reasonable prediction method
for the problem at hand (considering the limited amount of data
available, we refrained from seeking for an ‘‘optimal’’ method) and
to answer the question under what assumptions a prediction is
useful at all.
Methodological Approach
Predictive Modeling: Inference and Decision
The data relevant for predicting the outcome of a considered
diagnostic test are assumed to be organized as a vector of M
predictors, x~(x1,x2, . . . ,xM ). The predictors may be imagined
as the results of previous tests, where the term ‘test’ refers to the
broad-sense definition given in the Introduction. The basis for the
prediction is provided by data from N previous patients (training
set). It is assumed that for each of these patients not only the vector
of predictors, xn, is available, but also the outcome of the test, yn
(the index n, 1ƒnƒN , represents a consecutive patient number).
This study is confined to binary classifications, where the values 0
and 1 correspond to a negative and a positive outcome,
respectively. The corresponding classes are referred to as C0 and
C1. What exactly ‘‘positive outcome’’ means is often a matter of
definition. In fact, a test may first result in a continuous variable so
that it is necessary to reduce this outcome, in a subsequent step, to
a binary classification, for example by requiring that a certain
threshold is exceeded.
The objective of predictive modeling is to forecast, on the basis
of the data from the N previous patients, the test result (class
membership) for a new patient, for whom the vector of predictors
x was obtained. Two probabilistic approaches are used for that
purpose. The first approach, K-nearest neighbor classification,
goes back to ideas developed by Fix and Hodges in 1951, which
Predictive Modeling for Diagnostic Tests
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were only published many years later [16,17]. The applicability of
the method is limited by the fact that it cannot readily be used with
predictors corresponding to categorical variables (although there
are ways to overcome this restriction [18]). If the vectors of
predictors of both the previous patients and the new patient are
represented as points in an M-dimensional Euclidean space
(possibly after an appropriate metric adjustment [19]), the class
membership of the new patient can be predicted by determining
the nearest neighbours of this patient’s vector of predictors, x,
looking up the respective class labels, and finally taking a majority
vote [20]. Alternatively, instead of deciding straight away, a
posterior probability of class membership can be calculated as
p(CkDx)~Kk=K , where K is the number of neighbours considered
and Kk is the number of neighbours from class Ck[21]. The latter
approach has the advantage that it is, for example, possible to
account for the costs of false decisions, as will be explained below.
The second method is logistic regression, which represents an
application of the generalized linear model[22–24]. In essence, the
posterior probability of class C1 is obtained by evaluating the
logistic sigmoid function,
s(z)~
1
1z exp ({z)
, ð1Þ
for an argument corresponding to a linear combination of the
predictors [21], i.e.,
p(C1Dx)~s b0z
XM
m~1
bmxm
 !
: ð2Þ
The parameters bm (0ƒmƒM ) are estimated by maximum
likelihood, i.e., they are determined such that the probability of
obtaining the observed data is maximized [25]. In the present
study this was accomplished by calling the function ‘‘ GLMFIT’’
(with the link function ‘‘ LOGIT’’) of the MATLAB Statistics
Toolbox (The Mathworks, Inc., Natick, MA).
What the two methods have in common is that they provide
posterior probabilities of class membership. In a subsequent step,
these posterior probabilities can be used to decide whether or not
the new patient should be tested. The decision has to take into
account the cost for performing the test as well as possible harms
and benefits. This can be formalized by introducing a loss matrix
L (or, alternatively, a utility matrix defined as {L): The loss that
results from assigning a patient with a true class Ck to class Cj
corresponds to the element Lkj of the loss matrix (k and j may be
identical) [21]. The optimal decision is the one that minimizes the
expected loss. The corresponding decision rule is to assign a new
patient with predictor x to class Cj if and only if the expected loss
for this decision,
E½Lj ~
X
k
Lkj p(Ck Dx), ð3Þ
is smaller than the expected loss for any other decision [21]. With
only two classes, and because of p(C0Dx)~1{p(C1Dx), the rule for
an assignment to class C1 becomes p(C1Dx)wT , where T is a
threshold probability defined as
T~
L01{L00
L01zL10{L00{L11
: ð4Þ
With DL0~L01{L00 and DL1~L10{L11 the equation can be
rewritten as
T~
DL0
DL0zDL1
~
1
1zDL1=DL0
: ð5Þ
The same formula was obtained by Pauker and Kassirer [26],
although in a somewhat different context (therapeutic decision
making). They denoted DL0 as the cost and DL1 as the benefit.
Our understanding of cost and benefit is somewhat different.
Conceptually, we define ‘cost’ as the loss that would be caused by
performing a diagnostic test and accidentally erasing the result
before anybody could take notice of it. The difference in loss
between testing and not testing a patient is then the cost for testing
minus the benefit of the information provided by the test. If B0 and
B (with B0ƒCvB) are the benefits in the case of a negative and a
positive outcome, respectively, we get DL0~C{B0 and
DL1~B{C, and (5) simplifies to
T~
C{B0
B{B0
: ð6Þ
Provided that the sensitivity of the considered diagnostic test is
relatively low, as supposed in this study, it is justified to make the
simplifying assumption that a negative outcome has no benefit,
i.e., B0~0. The threshold T then corresponds to the cost-benefit
ratio C=B. A small benefit B0 does not invalidate this interpre-
tation: B0 reduces both the cost C and the benefit B so that T may
be interpreted as the ratio of the effective cost and the effective
benefit.
Evaluation of Predictive Modeling by Cross-validation
At least as important as knowing how to predict the outcome of
a considered diagnostic test is being able to evaluate the quality of
the prediction, which is the basic prerequisite for comparing the
performances of different approaches and their numerous variants.
The basis for the prediction are the data from N previous patients,
and exactly these data can be used to evaluate an algorithm before
applying it to make predictions for new patients. The method
which makes this possible is cross-validation. In the leave-one-out
approach [21,27,28] that will be used here, each of the previous
patients serves, in turn, for validation while the other N{1
patients represent the respective training set.
Cross-validation provides an easy way not only to compare
different approaches such as K-nearest neighbour classification or
logistic regression, but also to investigate which combination of
predictors yields the best prediction. Although this is an attractive
possibility, there is also a risk, because the procedure violates the
requirement that ‘‘when doing comparative evaluations, everything that is
done to modify or prepare the algorithms must be done in advance of seeing the
test data’’ [29]. Thus, if cross-validation is used to sift the approach
with the best performance out of a greater number of alternatives,
the capability to make correct predictions for unseen data (known
as generalization) may be low for the ‘‘winning’’ approach, and
this problem worsens as the number of cases in the training set
decreases [30]. To be able to recognize this problem, which is due
to overfitting, it is necessary to keep aside a certain proportion of
the dataset (test set) until these data are eventually used for
assessing the performance of the finally selected approach [21]. A
successful prediction can provide evidence that overfitting has not
occurred [31].
Predictive Modeling for Diagnostic Tests
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ROC Curve, Likelihood Ratio, and Related Issues
The performances of different approaches can be compared by
considering ROC curves. This necessitates to count, for a given
threshold T , the number of true-positives, NTP(T), false-positives,
NFP(T), true-negatives, NTN (T), and false-negatives, NFN (T).
The false-positive rate (i.e., 1{ specificity), is then calculated as
PFP(T)~
NFP(T)
NFP(T)zNTN (T)
ð7Þ
and the true-positive rate (sensitivity) as
PTP(T)~
NTP(T)
NTP(T)zNFN (T)
: ð8Þ
Moreover, the rate of positive predictions (corresponding to the
proportion of candidate patients that would be selected for testing
by the predictive model) can be calculated as
PP(T)~
NTP(T)zNFP(T)
N
: ð9Þ
Of interest are also the positive and the negative predictive
value [2,9]. In the present context, the positive predictive value,
PPV(T)~
NTP(T)
NTP(T)zNFP(T)
, ð10Þ
is the probability that a positive prediction as to the outcome of a
diagnostic would be confirmed by actually doing the test.
Accordingly, the negative predictive value,
NPV(T)~
NTN (T)
NTN (T)zNFN (T)
, ð11Þ
is the probability that a negative prediction would be confirmed.
A plot of PTP(T) versus PFP(T) yields the ROC curve, as
described in the Introduction. If different ROC curves are to be
compared it is convenient to characterize each curve by a single
number. The most popular one-number summary index is the
area under the curve (AUC) [2]. In this study, ROC curves were
obtained using the function ‘‘ perfcurve’’ of the MATLAB
Statistics Toolbox, which readily provides the AUC. If a binary
classification is based on a normally distributed continuous
variable which, for class Cj , has a mean of mj and a standard
deviation of sj , the AUC is
AUC~W
m1{m0ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s20zs
2
1
q
0
B@
1
CA, ð12Þ
where W(x) is the cumulative distribution function of a standard
normal distribution [2,32]. With the definition
da~
m1{m0ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
(s20zs
2
1)=2
q , ð13Þ
Eq. (12) can be rewritten as AUC~W(da=
ﬃﬃﬃ
2
p
), and solving for da
yields
da~
ﬃﬃﬃ
2
p
W{1(AUC), ð14Þ
where W{1 is the inverse of function W. The measure da, called
area related index [33], provides an alternative way to character-
ize a ROC curve. The advantage of this measure is that it can be
interpreted as a signal-to-noise ratio. In fact, under the assumption
of equal variances (s20~s
2
1), which appears to be reasonable for the
data considered in this article, da reduces to the widely used index
of dectability d ’[33,34]. The ROC curve corresponding to that
simple model has the parametric representation (1{W(t),
1{W(t{d ’)).
The ratio of true-positive and false-positive rate is known as the
likelihood ratio positive,
LRz~PTP=PFP, ð15Þ
which can be used to transform a pre-test probability (corre-
sponding to the prevalence of the condition tested for) into a post-
test probability [35,36]. For such a transformation it is convenient
to work with odds instead of probabilities. The odds corresponding
to a probability P are Q~P=(1{P), and given odds can be
converted into the corresponding probability using the formula
P~Q=(1zQ). If Q denotes the pre-test odds, then the post-test
odds are simply Qz~Q
:LRz.
Threshold Dependence of the Loss
After having investigated N patients, the expected loss for
testing a single patient can be estimated as
L(T)~C0z 1
N
(NTN (T)L00zNFP(T)L01zNFN (T)L10
zNTP(T)L11),
ð16Þ
where C0 denotes the cost caused by the prediction itself. If not
explicitly stated otherwise, the prediction is assumed to be made at
minimal expense on the basis of readily available data so that C0
will be set zero, for the sake of simplicity. In what follows, t is the
probability that a randomly selected candidate patient is tested
positive (prevalence of a positive test result). The above equation
can then be rewritten as
L(T)~C0zt:½L10zPTP(T):(L11{L10)
z(1{t):½L00zPFP(T):(L01{L00):
ð17Þ
This reformulation (which is equivalent to Eq. (3.5) in [37] for
C0~0 and to Eq. (2.17) in [15] for L00~0, although the contexts
differ) makes clear that not the individual losses, but only the
differences L11{L10 and L01{L00 are relevant when it comes to
comparing two prediction methods or the same method at
different thresholds (the terms tL10 and (1{t)L00 cancel out if
two expected losses are subtracted). Thus, two of the four losses
can be chosen ad libitum. Here, this indeterminacy is resolved by
postulating that a perfect classifier has a loss of zero, which
requires L00~L11~0. Referring to the above considerations
about costs and benefits we therefore get
L~
0 C{B0
B{C 0
 
ð18Þ
as the loss matrix. Equation (16) then simplifies to
Predictive Modeling for Diagnostic Tests
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L(T)~C0z 1
N
(NFP(T)(C{B0)zNFN (T)(B{C)): ð19Þ
A false-positive classification contributes the effective cost, C{B0,
whereas a false-negative classification contributes the missed
effective benefit, B{C. If the predictive model works well,
minimization of (19) with respect to T should yield a value that is
roughly consistent with the threshold obtained from (6).
In other contexts it can be advantageous to use a different loss
matrix. Here, we also consider the case that, in a research project,
a certain diagnostic test is an integral component of an elaborate
investigation which has to be completed before the outcome of the
test finally becomes available. But the investigation is assumed to
be of minor value if the outcome of the test is negative. It is
assumed, furthermore, that an ethical review board gave the
permission to investigate up to Ntest subjects. The goal of
predictive modeling, then, is to ensure that as many of the Ntest
subjects as possible are tested positive, while it may be acceptable
to falsely reject a large proportion of candidate subjects as being
ineligible for the test (false negatives). Under such circumstances,
C0 comprises not only the cost for making the prediction, but also
the costs for finding candidates and doing preinvestigations. These
screening costs may be quite substantial, setting an upper limit for
the number of subjects that can be screened. A suitable loss matrix
is
L~
0 C
0 C{B
 
: ð20Þ
The cost C is to be paid for each patient tested (true-positive as
well as false-positive predictions), whereas a benefit B is received
only for true-positive predictions.
As in the consideration before, the threshold T has to be
determined such that the expected loss is minimized. However,
Eq. (16) is not applicable here, because it is based on the
assumption that the total number of subjects, N, is a known
constant. But the number of subjects screened depends on T now.
To get a formula for the expected loss, it is helpful to first ask the
question as to how often the three losses (C0, C, and {B) can be
expected to arise. The number of patients required for screening
(each causing the loss C0) can be estimated by dividing Ntest by the
rate of positive predictions, PP(T). The number of subjects
actually tested (each causing the cost C) is, by definition, Ntest. The
number of tested subjects for which we can expect a positive
outcome (providing the benefit B) is obtained by multiplying Ntest
by the positive predictive value, PPV(T). In summary, the
expected loss for testing one of the Ntest subjects is
L(T)~CzC0=PP(T){PPV(T)B, ð21Þ
where PP(T) and PPV(T) are calculated using Eqs. (9) and (10),
respectively.
An Illustrative Example: The Glycerol Test
Background
Menie`re’s disease is characterized by episodes of vertigo,
hearing loss, and tinnitus or aural fullness. As yet, the diagnosis
is mainly based on the case history, the exclusion of other diseases,
and an elementary investigation of the patient’s hearing abilities.
Many efforts have been made to find objective correlates of
Menie`re’s disease [38,39], but there is still no method that could
be considered as the ‘gold standard’. One of the methods proposed
is the glycerol test [40], which relies on the fact that, in Menie`re
patients, oral application of glycerol can temporarily improve the
threshold of hearing, whereas the threshold does not systematically
change in normal hearing subjects or patients with other hearing
disorders. The glycerol test perfectly fits the category of tests that
was the focus of the above methodological considerations:
Although the test is assumed to have a high specificity, it is
discussed controversially because it is time-consuming, somewhat
uncomfortable for the patient, and not overly sensitive.
The glycerol test involves a comparison of two pure-tone
audiograms: The first one (pretest audiogram) is obtained
immediately before glycerol is orally administered to the patient,
and the second one is obtained a couple of hours later (four hours
in this study). The outcome is considered positive if the second
audiogram provides evidence of improved hearing (lower thresh-
olds in a certain frequency range). Many suggestions have been
made as to how the improvement should be ascertained. The
criterion used here is an aggregate threshold reduction (ATR) of at
least 30 dB in a contiguous frequency range. The criterion is
associated with a false-positive rate of approximately 5% [14].
A First Look at the Data
In a previous article [14] we presented a retrospective analysis of
N~356 glycerol tests in patients with suspected Menie`re’s disease.
Among other things, it was shown that the probability of a positive
test result depends on the pretest audiogram. A typical audiogram
comprises the thresholds of hearing at about 10 distinct
frequencies. While the thresholds are normally displayed in a
standardized form as hearing loss versus frequency, they may also
be arranged as a vector of predictors, x~(x1,x2, . . . ,xM ). It can
be useful to reduce the dimensionality of the original data, for
example by ignoring some frequencies or averaging thresholds
over certain frequency ranges. Moreover, it may be advantageous
to transform the original data, for example by subtracting two
thresholds. As a consequence, the number of predictors, M, may
be smaller than the number of estimated thresholds.
To illustrate the predictive value of the pretest audiogram, Fig. 1
shows all test results as points in a two-dimensional predictor
space: the abscissa represents the mean low-frequency hearing loss
(frequency range 150 to 1500 Hz), whereas the ordinate represents
the difference of mean high-frequency hearing loss (frequency
range 2000 to 8000 Hz) and mean low-frequency hearing loss.
The outcome of the test is indicated by the type of symbol. Most
common is a small cross, which indicates a negative outcome
(ATRv30). Circles, by contrast, represent a positive outcome (the
two types of filled circles indicate strong and very strong effects,
repectively). The distribution of the crosses clearly differs from the
distribution of the circles, especially from the distribution of the big
circles, which represent cases with ATR§125: Symbols repre-
senting patients that were tested positive are more likely to be
found below the zero line, which means that the hearing loss is
more pronounced in the low-frequency range. A related observa-
tion in our previous article [14] gave rise to a simple rule of thumb:
A positive outcome of the glycerol test is particularly likely if the
mean low-frequency hearing loss is between 30 and 70 dB and the
mean high-frequency loss does not exceed the mean low-frequency
loss. In Fig. 1, this concept is visualized as an area framed by thick
gray lines (the arrows indicate that there is no lower bound).
To draw quantitative conclusions, an exhaustive search
algorithm was used to identify regions where the probability of
finding an ATR of at least 30 dB is as high as possible (the borders
were systematically changed in steps of 5 dB; a similar analysis was
described in our previous article [14]). In Fig. 1, the area shaded in
Predictive Modeling for Diagnostic Tests
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gray is the optimal region under the constraint that at least 5% of
the cases are to be included. Solid and dotted lines bound optimal
regions comprising at least 20 and 50% of the cases, respectively.
More information is provided in Table 1, where also two
additional constraints (inclusion of at least 10% and 100% of the
cases, respectively) are considered. In the upper half of the table,
the optimized regions are defined, and it is stated how many cases
are actually found in those region. The lower half of the table
provides the probabilities that specific criteria are fulfilled. The
rightmost column was not obtained by optimization, but
represents the simple rule of thumb explained above, for the sake
of comparison. The table shows that the probability of obtaining a
positive test result can be substantially increased by testing only a
subpopulation of patients. For new patients, somewhat lower
probabilities are to be expected, though (see Discussion).
Predictive Modeling
A two-dimensional predictor space such as the one considered
in Fig. 1 has the advantage of being well-suited for visualization.
However, important information might get lost by reducing the
dimensionality of the data. In fact, the starting point for this study
was the question to what extent more sophisticated methods of
predictive modeling are superior to the above-mentioned rule of
thumb.
An evaluation of the K-nearest neighbor approach (with K~20)
by means of leave-one-out cross-validation is provided in Fig. 2.
The pre-test hearing losses at seven distinct frequencies (125–
3000 Hz) served to predict the outcome of the glycerol test, and
this prediction was checked against the true outcome. The choice
of the frequency range reflects the fact that higher frequencies are
generally of minor importance for Menie`re’s disease. Panel A
shows, as a function of threshold T , the number of true-positive
predictions (black curve with filled circles) and false-positive
predictions (gray curve with filled circles). The complementary
curves, representing the number of false-negative (black) and true-
negative predictions (gray), are shown as well, for the sake of
completeness. An appropriate rescaling yields the true-positive and
false-positive rates presented in panel B. The third curve in that
panel shows the rate of positive predictions, corresponding to the
proportion of candidate patients that would be subjected to testing.
Subsequent considerations will show that choosing a threshold of
0.5 (dotted vertical line) is a reasonable, although not necessarily
optimal strategy for the problem at hand. The rate of positive
predictions for this threshold is 0.38. Dividing the true-positive
rate by the false-positive rate yields the likelihood ratio LRz,
which is shown in panel C (only considering thresholds with more
than 20 positive predictions). For a threshold of 0.5, this ratio is
Figure 1. The results of all 356 glycerol tests projected into a two-dimensional predictor space. The two axes represent the mean low-
frequency hearing loss (horizontal) and the difference between mean high-frequency and mean low-frequency hearing loss (vertical). The type of
symbol indicates the aggregate threshold reduction (ATR) that was observed four hours after the glycerol intake. The gray area indicates the optimal
region under the constraint that at least 5% of the cases are to be included. Optimal regions with at least 20% and 50% of the cases are bounded by
solid and dotted lines, respectively. The area framed by thick gray lines with downward arrows represents a simple rule of thumb[?] according to
which a glycerol test should be considered as a diagnostic option when a patient with suspected Menie`re’s disease has a mean low-frequency
hearing loss between 30 and 70 dB and a mean high-frequency hearing loss that does not exceed the mean low-frequency loss.
doi:10.1371/journal.pone.0079315.g001
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2.11, which means that the odds of getting a positive test result are
more than doubled.
The curves in Fig. 2 D show the positive predictive value (black)
and the negative predictive value (gray). To ensure a certain
minimum quality of the estimated values, only thresholds with
more than 20 positive or negative predictions, respectively, were
considered. The choice of a small threshold is tantamount to
making a positive prediction for almost all patients. This explains
why, for T?0, the positive predictive value) corresponds to the
prevalence of a positive glycerol test, which is t&0:39 for the
present data (lower dotted line). Starting from this level, the
positive predictive value tends to increase with increasing
threshold. The choice of a threshold close to one, by contrast,
gives rise to a negative prediction for almost all patients. Thus, the
negative predictive value for T?1 is 1{t&0:61 (upper dotted
line).
A ROC-space representation of the the data points in Fig. 2 B is
provided in Fig. 3 (circles). Dotted lines mark the data point
corresponding to a threshold of 0.5. The smooth curve represents
a simple Gaussian model with an index of detectability (d ’) of
0:698 (the value was calculated from the estimated area under the
curve, as desribed in the context of Eq. (14)). Dashed lines indicate
different levels of the likelihood ratio LRz, namely 1 (the
diagonal), 2, and 3. It can be concluded that, for T§0:5, the
likelihood ratio LRz is typically between 2 and 3 (also shown in
Fig. 2 C). The filled square represents the above-mentioned rule of
thumb. Remarkably, this simple rule appears to perform similarly
to the investigated K-nearest neighbor approach for a threshold of
0:5.
The question remains how the investigated approach compares
to alternative prediction methods. An answer can be obtained by
comparing the AUC values compiled in Tab. 2. The first column
gives a mnemonic for the predictor space, the other columns
provide the AUC for the K-nearest neighbor approach and two
variants of logistic regression: one working only with the original
predictors (‘linear’), the other using the predictors squared as
additional predictors (‘quadratic’). The mnemonics nF (1ƒnƒ10)
refer to investigations in which the hearing losses at the lowest n
frequencies served as predictors. This means that 7F refers to the
predictor space considered in Figs. 2 and 3. The mnemonic LH
refers to a two-dimensional space with the mean low-frequency (L)
and the mean high-frequency hearing loss (H) as predictors
(considered in Fig. 8 of our previous article [14]). The space LH- is
identical, except that the predictor H is replaced by the difference
of H and L (considered in Fig. 1 of the present article). The
predictor space 7F3d operates on the same frequency range as 7F,
but the thresholds at neighboring frequencies were averaged
(pairwise, except for the three lowest frequencies), which reduced
the dimensionality from 7 to 3. The table suggests that, in spaces of
low dimensionality, the performance of logistic regression can be
moderately improved by including the squared predictors. All in
all, however, the K-nearest neighbor approach is superior. Its
performance improves as the number of frequencies increases, but
including more than 6 frequencies appears to be detrimental,
which would mean that the 7F space considered in Figs. 2 and 3 is
suboptimal. A comparison of the spaces 7F and 7F3d suggests that
reducing the dimensionality of the predictor space is advantageous
mainly for the quadratic version of logistic regression.
Cost-benefit Analyses
In what follows, it is investigated how the optimal threshold for
performing the glycerol test depends on the assumptions about
cost and benefit. The curves in Fig. 4 A, showing the expected loss
as a function of threshold, were calculated for the loss matrix
defined in Eq. (18), under the assumption that the cost for the test
is C~1 and that a negative outcome has no benefit, i.e., B0~0.
The numbers attached to the curves (1, 2, 3, and 10) indicate the
assumed benefit of a positive outcome, B. Since a benefit of 1
merely recoups the cost for testing, the expected loss increases as
the threshold decreases, owing to the increasing proportion of
patients for whom no benefit could be achieved. The optimal
strategy, therefore, is to refrain from testing. For a benefit of 2, a
flat minimum can be observed at a threshold of 0:5. The
highlighted curve (thick with filled symbols) represents the special
case that the benefit is equal to the reciprocal of the prevalence of
a positive test result, i.e., B~1=t&2:54. The expected loss for
T?1 is obtained by multiplying t (now corresponding to the false
negative-rate) by B{C~1=t{1, yielding 1{t. This is also the
expected loss for T?0 (irrespective of the assumed benefit). The
minimal loss is obtained for a threshold of 0.5 or somewhat below.
For a benefit of 3, the optimal threshold is about 0.35, and
refraining from testing (T?1) is worse than testing all subjects
(T?0). For a benefit of 10, the optimal strategy would be to test
almost every patient, because the missed benefit from a false-
negative decision represents a quite significant loss.
Figure 4B refers to the situation that a scientific study with a
fixed number of subjects would be most beneficial if an embedded
glycerol test has a positive outcome in as many subjects as possible
(see Eq. (21)). The cost for performing the test is, again, assumed to
be 1, whereas the benefit of a positive test result is set to 10. The
numbers attached to the curves (1/8, 1/4, 1/2, 1, and 2) indicate
the cost for screening, C0. In the case of the highlighted curve
Table 1. Optimal pretest conditions for the criterion ATR§30.
Percentage of cases to be included Rule of thumb
$5 $10 $20 $50 100
Actual number of cases 21 36 76 182 356 127
Pretest loss (dB HL)
at low frequencies 6065 55610 55615 60620 50650 50620
high minus low freqs. 215610 215610 220615 220630 0645 #0
Probability
of ATR $30 0.86 0.75 0.67 0.51 0.39 0.57
of ATR $50 0.62 0.56 0.46 0.31 0.22 0.37
of ATR $125 0.24 0.19 0.14 0.066 0.037 0.094
doi:10.1371/journal.pone.0079315.t001
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(thick with filled symbols), which may serve as a reference, the cost
for screening is significantly smaller than the cost for actually doing
the test, but it is not negligible (C0~1=4). A threshold of about 0.5
turns out to be optimal in this situation. Doubling the cost for
screening does not fundamentally change the situation, whereas
halving shifts the optimal threshold to the right, meaning that the
choice of subjects should become more selective. As to be
expected, screening for suitable subjects is of limited value if this
causes the same cost as actually doing the test (C0~1), and
screening becomes counterproductive if the cost is higher (C0~2).
Discussion
Decision Making based on the Cost-benefit Ratio
The predictive modeling approaches considered in this article
use the experiences with previous patients for estimating the
probability that performing a specific diagnostic test in a new
patient will have a positive outcome. If the model underlying the
prediction were perfect, the optimal strategy would be to test a
patient whenever the estimated probability exceeds the threshold
defined in Eq. (6), which corresponds to the cost-benefit ratio C=B
(under the simplifying assumption that a negative test result has no
benefit). However, if the goodness of the predictive model is
unknown, this simple rule is suitable only for qualitative
considerations. Problems are to be expected, for example, when
a K-nearest neighbor prediction is to be made for a point located
in the periphery of the points representing the previous patients:
The estimated probability may then be representative for the
center of the K neighbors, but not for the eccentrically placed
point of interest. A cost-benefit analysis using cross validation (as in
Fig. 4) does not only assess the true performance of the model, but
also gives an idea of how suboptimal decisions deteriorate the
performance.
Instead of considering the expected utility of the diagnostic test,
we modeled its negative counterpart: the expected loss. It is, of
course, not possible to unconditionally generalize the results
obtained for the illustrative example presented above, the glycerol
test. However, some conclusions are probably valid for other
diagnostic tests as well, especially since the parameters in the loss
matrix are, as a rule, not precisely known. Thus, a more qualitative
interpretation of our numerical results is advisable anyway.
Regarding the analysis presented in Fig. 4 A it appears appropriate
to distinguish three major conditions. Firstly, the benefit of a
positive test result may very clearly exceed the cost (e.g.,
B=C~10). Excluding a patient from testing because of an
erroneously predicted negative outcome would cause a significant
loss, and so a low threshold has to be chosen (e.g., T~0:1, in
accordance with Eq. (6)), which means that almost every patient is
Figure 2. Prediction of a positive outcome of the glycerol test
by K-nearest neighbor classification. (A) The curves with filled
circles show, as a function of threshold, the numbers of true-positive
(black) and false-positive predictions (gray). The other curves show the
numbers of false-negative (black) and true-negative predictions (gray).
(B) The curves with filled circles show the true-positive rate (black) and
the false-positive rate (gray). The other curve shows the rate of positive
predictions, corresponding to the proportion of candidate patients that
would be subjected to testing. (C) Likelihood ratio LRz. (D) Positive
predictive value (black) and negative predictive value (gray).
doi:10.1371/journal.pone.0079315.g002
Figure 3. Receiver operating characteristic. The open circles
represent the false-positive and true-positive rates displayed in Fig. 2 B,
whereas the filled square represents the rule of thumb considered in
Fig. 1. The three dashed lines indicate specific values of the likelihood
ratio LRz (1, 2, and 3).
doi:10.1371/journal.pone.0079315.g003
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tested. Secondly, the benefit may not be significantly higher than
the cost. In that case, it is advisable to choose a threshold close to 1
(again in accordance with Eq. (6)), which corresponds to refraining
from testing. Thirdly, the benefit may be in between the two
extremes (e.g., benefit-cost ratio of 2 or 3). A threshold of T~0:5
may then be considered as a reasonable default choice. Depending
on the cost-benefit ratio, this choice may be suboptimal, but the
disadvantage compared to the optimal choice can be expected to
be small. A particularly interesting situation arises if the benefit-
cost ratio equals the reciprocal of the prevalence of a positive test
result (thick curve with filled circles in Fig. 4 A): Testing all patients
(T~0) and testing no patient (T~1) causes exactly the same loss,
which is greater than the loss for any intermediate threshold. With
respect to decision making this means that testing a subpopulation
selected by predictive modeling is, in any case, better than the two
extreme alternatives: testing each patient or no patient at all.
Comparison with Related Work
Our approach is closely related to decision curve analysis as
proposed by Vickers and Elkin [41]. While we use a loss matrix,
they assign a ‘value’ to each outcome of a simple decision tree,
which is, of course, equivalent. Moreover, their equation (1)
corresponds to our equation (4). Remarkably, the unnumbered
equation on page 567 of their article is a special case of our
equation (17). To show this, we transcribe their equation using our
own notation (we also apply their Eq. (1) and account for the fact
they fixed a{c at 1):
{L(T)~NTP(T)
N
{
NFP(T)
N
(({L00){({L01)) ð22Þ
The equation can be rewritten as
L(T)~{tPTP(T)z(1{t)PFP(T)(L01{L00), ð23Þ
which is equivalent to (17) if C0~L00~L10~0 and L11~{1.
Note that the only free parameter in the loss matrix, L01, can be
interpreted as a cost-benefit ratio. The assumption L00~0 (also
made in the present article) is without any reasonable alternative.
Worded in neutral terms it means that refraining from action in
cases where no action is required causes a loss of zero. The
assumption L10~0 in the approach by Vickers and Elkin is
consistent with our definition of a loss matrix in Eq. (20). Worded
in neutral terms again, the zero of the loss scale is assigned to the
Figure 4. Expected loss as a function of threshold (cost-benefit analysis for the glycerol test). (A) Analysis based on the loss matrix
defined in Eq. (18). The cost for the test is C~1, a negative test result has no benefit (B0~0), and a positive test result has the benefit indicated by
the number attached to each of the four standard curves (1, 2, 3, and 10). In the case of the highlighted curve (thick with filled symbols), the benefit is
the reciprocal of the prevalence of a positive test result. (B) Analysis based on the loss matrix defined in Eq. (21). The cost for performing the test is 1
and the benefit of a positive test result is 10. The numbers attached to the curves indicate the cost for screening.
doi:10.1371/journal.pone.0079315.g004
Table 2. Comparison of various prediction methods in terms
of the area under the ROC curve (AUC).
space K-nearest logistic regression
neighbor linear quadratic
1F 0.594 0.600 0.603
2F 0.624 0.609 0.629
3F 0.688 0.615 0.628
4F 0.667 0.616 0.623
5F 0.688 0.615 0.621
6F 0.704 0.641 0.635
7F 0.689 0.636 0.628
8F 0.678 0.631 0.619
9F 0.652 0.629 0.615
10F 0.655 0.623 0.605
LH 0.634 0.635 0.648
LH- 0.657 0.635 0.650
7F3d 0.690 0.655 0.674
doi:10.1371/journal.pone.0079315.t002
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situation that, regardless of any predictive information, no action is
taken. By contrast, in the loss matrix defined in Eq. (18) we assume
L11~0, which means that the zero is assigned to the hypothetical
situation that decisions about an envisaged action are made using
a perfect classifier. However, as already explained in the context of
Eq. (17), the definition of the zero point is irrelevant when
comparing two methods. In conclusion, up to here our approach is
basically equivalent to that of Vickers and Elkin [41].
The crucial difference is the way Eq. (4) is handled. Vickers and
Elkin [41] assign a pivotal role to this equation in that they
consider cost-benefit ratio and threshold probability as measures
that can be converted into each other as desired. By contrast, we
consider Eq. (4) as a theoretical relationship that cannot be
expected to be strictly valid when dealing with real-world
problems. We therefore ignore the equation in the first instance
and consider threshold probability and benefit-cost ratio as
parameters that can be independently varied. Plotting a family
of curves as in Fig. 4 A is a convenient means to visualize how
these two parameters affect the expected loss. Under ideal
conditions, each curve would show a minimum at the threshold
predicted by Eq. (4). Thus, the minima of the curves would be
located on a graph comparable to the decision curve of Vickers
and Elkin (of course, the fact remains that we consider loss rather
than ‘value’ and that we define the zero point in a different way).
Although our results roughly confirm this expectation, two aspects
prevent perfect agreement. First, the optimal threshold calculated
using Eq. (4) refers to the expected value of the loss, whereas our
estimations are based on limited data. Second, the benefit-cost
ratio is a continuous variable, whereas, for the K-nearest neighbor
method considered in Fig. 4 A, the threshold probability is of a
discrete nature.
Despite these formal discrepancies, it can be assumed that our
approach and that of Vickers and Elkin [41] generally lead to
similar conclusions. Thus, from the users’ point of view the
differences between the two approaches are chiefly of a practical
nature. In the approach by Vickers and Elkin, the user is assumed
to already have an opinion about the threshold probability (and
thus, implicitly, also about the cost-benefit ratio). Decision curve
analysis can then be used to check whether it is sensible to apply
this threshold to decision making using a specific predictive model.
By contrast, our approach allows for the possibility that a user
might have nothing more than a vague idea of the benefit-cost
ratio. The questions asked under such circumstances are inevitably
less focused, and a multi-step procedure might be appropriate. In
the first step, it could be investigated for which range of benefit-
cost ratios the predictive model promises to be beneficial.
Supposing that this range includes the presumed benefit-cost
ratio, the next step would be to determine the optimal threshold.
Finally, it might be of interest to ask whether this threshold would
be acceptable also for slightly different assumptions about the
benefit-cost ratio. A plot such as the one in Fig. 4 A appears to be
well-suited for considerations of this kind.
We are not aware of other articles coming as close to ours as
does that of Vickers and Elkin [41]. But, of course, many authors
considered related problems. For example, Moskowitz and Pepe
[42] proposed a method for quantifying and comparing predictive
accuracy of continuous prognostic factors. Their work differs from
ours in that they consider single factors, whereas we consider
multiple factors. Nevertheless, their idea of a standardized scale
based on the cumulative distribution function of the respective
prognostic factor could be useful also in the context of our K-
nearest neighbor approach, because that way it would be possible
to build up meaningful predictor spaces from factors of quite
different nature (such as hearing loss and age). Another difference
between our approach and that of Moskowitz and Pepe [42] is that
we pursue loss minimization, whereas they advocate considering
positive and negative predictive values. For the sake of conciseness,
we abstain from comprehensively reviewing possible alternatives to
our methodological approach. Instead, we refer to a review article
by Gerds et al. [43]. They not only illuminate the broader context,
but also present a unifying framework that shows clear parallels to
our approach. Risk prediction models, as considered in their
article, use prognostic factors available at time t~0 to determine
the probability of a patient having a certain status at time t§0. In
our article, ‘status’ refers to the outcome of the glycerol test, and
the prediction is evidently made for time t~0. Amongst other
things, Gerds et al. [43] compare traditional methods such as
logistic or Cox regression with machine learning concepts such as
classification trees and random forests. The former belong to the
culture of data modeling, whereas the latter, just as the nearest
neighbor method considered in the present article, belong to the
culture of algorithmic modeling [44]. Gerds et al. [43] urge that
performance measures should be applicable to all statistical
cultures, and they regard crossvalidation and bootstrap to be the
heart of internal validation. Our study is in line with these
concepts. Moreover, their idea that the predicted probabilities can
be considered as a new ‘single continuous marker’ corresponds to
our interpretation of predictive modeling as a virtual screening
test.
Comparison of Predictive Modeling Approaches
Diagnostic testing is most useful when the presence of disease is
neither very likely nor very unlikely [1]. The information theoretic
explanation of this fact is that a test with a binary result (Yes/No
decision) is most informative if the two alternatives have the same
probability, because this is the condition under which the binary
entropy function reaches its maximum (corresponding to one bit)
[45]. The glycerol test considered here approximately satisfies this
condition: The prevalence of a positive test result was almost 0.4
for the population of candidate patients, and with predictive
modeling the positive predictive value increased up to about 0.6
(see Fig. 2 D), which means that the odds of obtaining a positive
test result were more than doubled. It should be noted that this
improvement was achieved with a relative simple predictive
model, which was defined before the data were analyzed. Table 2
suggests that this model (K-nearest neighbor approach for the
space 7F) is probably suboptimal, which means that a better
performance might be attainable by employing a different
combination of predictors, possibly with optimized weights
(although the gain to be made by weighting may not be worth
the extra effort [46]). However, in view of the limited amount of
data available, we refrained from systematically seeking for an
optimal model, because this would involve the risk of overfitting,
with the consequence that the optimized model may not
generalize well to new data [30]. Besides, as long as the analysis
depends on rough guesses of cost and benefit, reaching indisput-
able conclusions is impossible anyway.
But these limitations do not preclude a more general
comparison of methods. A convenient possibility is to calculate
the area under the ROC curve (AUC), although the approach
must be considered with reservation because this widely used
measure was shown to be incoherent [47,48]. We start the
discussion of Tab. 2 by considering the predictor space LH-. The
visualization of this space in Fig. 1 shows that the probability of a
positive test result is clearly enhanced if the predictor represented
by the horizontal axis (low-frequency hearing loss) has an
intermediate value. A linear regression model is not able to
adequately account for this observation, and therefore it is not
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surprising that including the predictors squared as additional
predictors yields an improvement: Even though the effect is
relatively small, the quadratic version of logistic regression
approximately reaches the performance of the K-nearest neighbor
approach in this space. The latter method is distinguished by the
fact that predictions are made locally, on the basis of small subsets
of data. This gives the method a high flexibility, which may
explain why it turned out to be superior in spaces of higher
dimensionality (greater than two). An additional reason for this
superiority is that the inclusion of quadratic terms in the logistic
regression approach is apparently counterproductive when the
dimension of the space is greater than five, presumably because
generalization to new data becomes a problem.
A comparison of the spaces 1F to 10F confirms the initial
hypothesis that the hearing thresholds at the three highest
frequencies have no predictive value. To be exact, Tab. 2 suggests
that only the thresholds at the six lowest frequencies contribute
substantial information (K-nearest neighbor approach and linear
logistic regression are consistent in this respect). A comparison of
the spaces 7F and 7F3d suggests that averaging over appropriately
chosen frequency bands can improve the performances of the two
variants of logistic regression, whereas there is no obvious
advantage for the K-nearest neighbor approach. However, for
other data transformations the situation may be the other way
around, as suggested by a comparison of the spaces LH and LH-.
The latter was derived from the former by subtracting the two
predictors and substituting the result for one of the original
predictors. While this step had basically no effect on the
performances of the two logistic regression approaches, the
performance of the K-nearest neighbor approach slightly im-
proved. Thus, it is conceivable that more complex and possibly
nonlinear transformations of the data (resulting in predictors that
describe the shape of the pretest audiogram in terms of, e.g.,
‘curvature’ or ‘frequency of the steepest gradient’) would allow us
to outperform the approaches considered in Tab. 2. Nevertheless,
it appears doubtful that striking improvements are possible without
introducing additional predictors. To better characterize the
pretest hearing status, it might be helpful to consider, for example,
measures of frequency selectivity and compression [49].
Predictive Modeling versus Simple Rule of Thumb
A simple rule of thumb turned out to be competitive with the
much more sophisticated predictive modeling approaches. This
result was not expected, but it is not too surprising either. There
are probably two reasons that contributed to this outcome. First,
the use of expert knowledge of the condition tested for avoids the
need to make potentially unreliable estimations based on a limited
amount of data (e.g., considering the K nearest neighbors). If the
key information contained in the predictors can be captured by a
simple rule (which, in the present example, apparently concerns
the relationship between low- and high-frequency hearing loss), it
may be difficult for unspecific prediction methods to achieve a
significantly better performance. The argument is supported by
the fact that the predictor space underlying the rule of thumb (LH-
) is only a mediocre choice (see K-nearest neighbor method in
Tab. 2). In reverse, this means that it might be worthwhile to seek
for a rule of thumb operating in a different low-dimensional space
(such as 7F3d). Second, the data used for establishing and
evaluating the rule of thumb were the same. Thus, it might be the
case that applying the rule to new data would result in a somewhat
lower performance. The predictive modeling approaches, by
contrast, were evaluated using cross-validation so that there is no
reason to assume that the performance will differ for a population
of new patients, provided that the external conditions and the
inclusion criteria remain the same. Regardless of these consider-
ations, predictive modeling has the principle advantage that the
proportion of patients tested can easily be varied by adjusting the
threshold, thus allowing us to account for the presumed cost-
benefit ratio of the test. The latter may critically differ even from
patient to patient. For example, a test providing mainly prognostic
information [50] is beneficial only to patients who want to know
the prognosis.
Conclusions
The performance of a diagnostic test is commonly characterized
in terms of its sensitivity and specificity. However, these two well-
known measures are not necessarily sufficient for assessing how
useful a test is in daily practice. To reach a well-founded
conclusion, it is indispensable to consider additional factors such
as the cost for performing the test and the benefit of a positive and
a negative test result, respectively. Of crucial importance is also the
prevalence of the condition tested for, which, by definition,
depends on the population of patients. Thus, the utility of a test
may crucially depend on how the tested patients are selected. As
yet, the selection is typically based on relatively coarse criteria.
The patients may, for example, be suspected of having a certain
disease. Predictive modeling opens up the possibility to come to
individualized decisions, with the consequence that a diagnostic
test may be considered useful for a particular patient even when
testing a broader population of patients with the same suspected
diagnosis is discussed controversially. Moreover, if alternative tests
are available, predictive modeling may help to choose the one that
is most promising for the particular patient.
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